Listen "How Real-World Evidence Is Transforming Prostate Cancer Care: What Clinicians Can Learn from Apalutamide vs Enzalutamide"
Episode Synopsis
This episode explores how real-world evidence (RWE) is changing prostate cancer treatment and decision-making. You’ll learn how RWE complements randomized controlled trials (RCTs) and provides deeper insight into long-term outcomes, adherence, and diverse patient populations.In this episode, you’ll learn:Why RWE is becoming essential in modern prostate cancer careHow apalutamide compares to enzalutamide in metastatic castration-sensitive prostate cancer (mCSPC)What the 23% lower mortality risk with apalutamide means for clinicians and patientsThe strengths and limitations of real-world studies versus RCTsHow RWE can help personalize treatment and improve shared decision-makingWhy is a rigorous study design critical to maintain RWE credibilityThe future of RWE, including integration with biomarkers and long-term dataDiscover how RWE is helping oncologists bridge the gap between clinical trials and real-world patient care.Blog Link: How Real-World Evidence Is Transforming Prostate Cancer Treatment DecisionsSend us a textThank you for listening to The Onco Life Podcast, your trusted source for expert cancer information and patient-centered education. Author: Dr. CHRISTINA NG VAN TZE 📍 Visit us at oncolifecentre.com 📞 Call: +603-2242-2620 📧 Book a consultation or ask a question — we're here to support your journey.
More episodes of the podcast The Onco Life Podcast
Early Stage Liver Cancer Treatment: Best Options for Stage 1 Patients and Long-Term Survival
18/10/2025
Immunotherapy for Liver Cancer: How Advanced HCC Patients Benefit From Immune-Based Treatments
16/10/2025